In vitro/in vivo evaluation of an optimized fast dissolving oral film containing olanzapine co-amorphous dispersion with selected carboxylic acids

scientific article published on 10 March 2016

In vitro/in vivo evaluation of an optimized fast dissolving oral film containing olanzapine co-amorphous dispersion with selected carboxylic acids is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/10717544.2016.1153746
P698PubMed publication ID26960680
P5875ResearchGate publication ID297753282

P2093author name stringAhmed Mahmoud Abdelhaleem Ali
Ahmed Abdelbary Abdelrahman
Eman Magdy Maher
Heba Farouk Salem
P2860cites workCharacterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymersQ28216525
Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.Q33249551
Fast dissolving strips: A novel approach for the delivery of verapamilQ34373809
Oral strip technology: overview and future potentialQ34989363
Characterization and optimization of orodispersible mosapride film formulations.Q35577232
Characterization of oral disintegrating film containing donepezil for Alzheimer diseaseQ35821872
Development and Characterization of a Vaginal Film Containing Dapivirine, a Non- nucleoside Reverse Transcriptase Inhibitor (NNRTI), for prevention of HIV-1 sexual transmissionQ36033871
A review on mouth dissolving filmsQ37596472
Advances in orodispersible films for drug deliveryQ37834030
Solid lipid nanoparticles: an oral bioavailability enhancer vehicleQ37914880
Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs.Q37977737
Water soluble polymer films for intravascular drug delivery of antithrombotic biomoleculesQ39659901
Formation Mechanism of Coamorphous Drug-Amino Acid Mixtures.Q40854029
Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model.Q41032711
Formulation of a novel tianeptine sodium orodispersible filmQ41867207
Design of olanzapine/lutrol solid dispersions of improved stability and performancesQ41998882
Plasticizer effects on physical-mechanical properties of solvent cast Soluplus® filmsQ42574249
Development of a taste-masked orodispersible film containing dimenhydrinate.Q42876082
Optimization of propranolol HCl release kinetics from press coated sustained release tabletsQ44189428
Buccal films of prednisolone with enhanced bioavailabilityQ45209173
Development of a buccal mucoadhesive film for fast dissolution: mathematical rationale, production and physicochemical characterizationQ45375065
Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancementQ45811011
Optimized sildenafil citrate fast orodissolvable film: a promising formula for overcoming the barriers hindering erectile dysfunction treatment.Q46183523
Design of freeze-dried Soluplus/polyvinyl alcohol-based film for the oral delivery of an insoluble drug for the pediatric use.Q46513438
Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studiesQ48950555
Clozapine-carboxylic acid plasticized co-amorphous dispersions: Preparation, characterization and solution stability evaluationQ50444533
Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions.Q51082669
Particle engineering/different film approaches for earlier absorption of meloxicam.Q51137697
Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.Q51542358
The effect of experimental design on the modeling of a tablet coating formulation using artificial neural networks.Q52942583
Role of the Strength of Drug–Polymer Interactions on the Molecular Mobility and Crystallization Inhibition in Ketoconazole Solid DispersionsQ57374585
Solid state characterization of olanzapine polymorphs using vibrational spectroscopyQ58861836
Preparation and characterization of spray-dried co-amorphous drug-amino acid saltsQ59234161
P433issue8
P407language of work or nameEnglishQ1860
P304page(s)3088-3100
P577publication date2016-03-10
P1433published inDrug DeliveryQ5308838
P1476titleIn vitro/in vivo evaluation of an optimized fast dissolving oral film containing olanzapine co-amorphous dispersion with selected carboxylic acids
P478volume23

Reverse relations

cites work (P2860)
Q91603846Advances in coamorphous drug delivery systems
Q47267991Biomimetic synthesis of proline-derivative templated mesoporous silica for increasing the brain distribution of diazepam and improving the pharmacodynamics of nimesulide.
Q64902990Co-Amorphous Solid Dispersions for Solubility and Absorption Improvement of Drugs: Composition, Preparation, Characterization and Formulations for Oral Delivery.
Q49496136Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability
Q39410919Formulation, in vitro evaluation and kinetic analysis of chitosan-gelatin bilayer muco-adhesive buccal patches of insulin nanoparticles
Q90477980In vitro and in vivo characterization of domperidone-loaded fast dissolving buccal films

Search more.